IRONWOOD PHARMACEUTICALS, INC. Deferred Tax Assets, Goodwill and Intangible Assets
IRONWOOD PHARMACEUTICALS, INC. (IRWD) had Deferred Tax Assets, Goodwill and Intangible Assets of $3.62 million as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets · last filed 2026-02-26
- 2025-12-31: Deferred Tax Assets, Goodwill and Intangible Assets $3.62M.
- 2024-12-31: Deferred Tax Assets, Goodwill and Intangible Assets $3.41M.
- 2023-12-31: Deferred Tax Assets, Goodwill and Intangible Assets $10.97M.
- 2022-12-31: Deferred Tax Assets, Goodwill and Intangible Assets $5.30M.
| Period end | Deferred Tax Assets, Goodwill and Intangible Assets |
|---|---|
| 2025-12-31 | $3.62M 10-K · filed 2026-02-26 |
| 2024-12-31 | $3.41M 10-K · filed 2026-02-26 |
| 2023-12-31 | $10.97M 10-K · filed 2025-03-31 |
| 2022-12-31 | $5.30M 10-K · filed 2024-02-16 |
| 2021-12-31 | $5.40M 10-K · filed 2023-02-16 |
| 2018-12-31 | $25.93M 10-K · filed 2020-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |